The President's Distinguished Lecture Series

Engineering Better Outcomes: Innovation, Leadership and the Future of Healthcare 

Mr. Greg Lucier
Executive Chairman and Chief Executive Officer 
Corza Medical

WEDNESDAY, NOVEMBER 18, 2026, AT 4 P.M. 
UNIVERSITY CENTER, TECH FLEX AUDITORIUM

Register Now | Seating limited. Registration required.

Presentation of the President's Medal to Mr. Lucier and reception immediately following the President's Distinguished Lecture.

ABSTRACT: Healthcare is undergoing a profound transformation driven by demographic shifts, rapid technological advancement and increasing demands for better patient outcomes at lower cost. Yet the greatest innovations in healthcare are never about technology alone — they happen when engineers, scientists, clinicians and business leaders work together with one shared purpose: improving patients' lives. 

Drawing on nearly four decades of leadership across the life sciences and medical technology industries, Greg Lucier explores how breakthrough ideas become real-world improvements in patient care. Through stories and lessons from his career, he examines the journey from scientific discovery to patient impact, highlighting the essential roles of engineering, clinical evidence, manufacturing excellence, commercialization, organizational leadership and collaboration. 

Designed for students, faculty and industry leaders alike, this lecture offers an inspiring perspective on the future of healthcare — and challenges the next generation to transform innovation into meaningful outcomes for patients around the world. 

BIOGRAPHY: Greg Lucier is the Executive Chairman and CEO of Corza Medical, a surgical technologies company he founded in partnership with GTCR, a leading private equity firm based in Chicago. With more than $500 million in annual revenue and 3,000 employees, Corza provides essential surgical tools and technologies to surgeons, healthcare providers and caregivers worldwide. 

Lucier’s 35+ years of life sciences leadership with GTCR’s unrivaled track record of creating unique, value-generating private equity opportunities has positioned Corza Medical as a trusted partner for improving clinical, operational and financial outcomes across ophthalmology, wound closure, biomedical textiles and biosurgery. 

Prior to Corza, Lucier served as Chairman and CEO at NuVasive, a technology leader in minimally invasive spine and orthopedic surgery, that later sold to Globus Medical for over $3 billion. He was also Chairman and CEO at Life Technologies, which he grew into a global life sciences powerhouse with over $4 billion in sales that was acquired by Thermo Fisher Scientific for more than $15 billion. 

Lucier spent the first stage of his career with General Electric — including GE Healthcare — ultimately serving as President, Medical Information Technologies. 

Lucier serves on several public and private company boards, including Dentsply Sirona, Maravai LifeSciences, Lighteum Medical and Avantor. He holds a B.S. in Industrial Engineering from Pennsylvania State University and an MBA from Harvard Business School. 

ATTENDANCE: This event is open to all Stevens students, faculty, staff, alumni and invited guests.

Discrimination notice: Persons of all identities are invited to and included in this group. Stevens does not discriminate against any person on the basis of sex, race, religion, disability, sexual orientation, gender expression, or any other basis prohibited by law.

Photo and video notice: At any time, photography or videography may be occurring on Stevens’ campus. Resulting footage may include the image or likeness of event attendees. Such footage is Stevens’ property and may be used for Stevens’ commercial and/or noncommercial purposes. By registering for and/or attending this event, you consent and waive any claim against Stevens related to such use in any media. See Stevens' Privacy Policy for more information.